What is the role of antiplatelet therapy in the initial treatment of transient ischemic attack (TIA)?

Updated: Dec 03, 2018
  • Author: Ashish Nanda, MD; Chief Editor: Andrew K Chang, MD, MS  more...
  • Print

In view of the high short-term risk of stroke after TIA, antithrombotic therapy should be initiated as soon as intracranial hemorrhage has been ruled out. For noncardioembolic TIA, the following antiplatelet agents are all reasonable first-line options for initial therapy:

  • Aspirin (50-325 mg/day)

  • Aspirin plus extended-release dipyridamole

  • Clopidogrel

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!